| Financial Year |
March 31 2023 |
| Monetary Funds |
615,178,058.10 |
| Held-for-trading Financial Assets |
290,000,000.00 |
| Notes Receivable |
177,644,024.40 |
| Accounts Receivable |
813,287,574.62 |
| Advances to Suppliers |
71,531,811.69 |
| Other Receivables |
37,180,196.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,054,114,614.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,373,632.54 |
| Total Current Assets |
3,171,549,562.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,636,584.60 |
| Investment Properties |
23,980,986.68 |
| Fixed Assetes |
1,410,271,840.76 |
| Under-construction Projects |
330,681,047.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
932,039,929.24 |
| R&D expenses |
215,355,993.32 |
| Goodwill |
804,209,260.84 |
| Long-Term Deferred and Prepaid Expenses |
23,111,679.68 |
| Deferred Income Tax Assets |
153,927,489.81 |
| Other Non-Current Assets |
142,625,945.32 |
| Sub-Total of Non-Current Assets |
4,237,864,249.20 |
| Total Assets |
7,409,413,811.28 |
| Short-Term Loans |
1,036,626,925.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
289,464,374.91 |
| Accounts Payable |
853,107,448.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
124,425,678.07 |
| Taxes Payable |
70,512,319.79 |
| Interest Payable |
-- |
| Dividend Payable |
209,201,636.88 |
| Other payables |
273,504,924.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
495,070,756.51 |
| Other Current Liabilities |
237,940,664.81 |
| Sub-Total of Current Liabilities |
3,464,795,292.15 |
| Long-term Loans |
524,341,035.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,047,729.41 |
| Deferred Income Tax Liabilities |
167,876,439.36 |
| Other Non-Current Liabilities |
323,400,000.00 |
| Sub-Total of Non-Current Liabilities |
1,121,050,223.96 |
| Total Liabilities |
4,585,845,516.11 |
| Paid-In Capital(Or Share Stock) |
132,075,636.00 |
| Capital Surplus |
1,071,267,786.68 |
| Surplus Reserve |
54,922,555.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
324,203,393.92 |
| Minority Stockholder's Interest |
1,238,049,608.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,585,518,686.49 |
| Owner's Equity（Stockholder's Equity） |
2,823,568,295.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,409,413,811.28 |
